August 2011 Life Science Market Review:Winners and Losers
Worse August in a Decade Down 6%-Economic Data Still Foreboding and Macro Headwinds Remain If you were on vacation for the month of August and reviewed your "balanced" portfolio today you might wonder what everyone was freaking out about. Treasuries were up big. The DOW just turned positive for...
Stealth Rally Continues Despite Weak Economic Forecasts: Life Science Stocks Up Over 2.5%
Personalized Medicine Achieves Milestone with Lung Cancer Drug Friday's rally picked up steam today as devastation from Hurricane Irene was less than expected and consumer spending was up. Greek stocks also rallied on a bank merger. Why are Greek stocks boosting this market? NASDAQ and the...
Stocks Rally as Fed Shifts to Idle: Biotechs Strong ILMN, SGEN
Can Congress Ignore a 78% Disapproval Rating? All the anticipation of the FED and Jackson Hole went to the ZEN mode-do nothing and the market will rally. Investors apparently were interpreting this as the economy isn't bad enough to warrant stimulus. Around 10:25am today NASDAQ went into an...
Risk Off: Day Traders and Robots Rule
A day before the Bernanke addresses the public on potential FED plans and the state of the economy the market reverted back to the Euro Debt crisis selling tracking the European stocks decline. The market major indices sold off 1.5% while the FTSE-100 was off 1.44%. NASDAQ was off 1.95%. The...
Three Days of Market Gains: Biotechnology Trades Are Holding
Drug Stocks with Dividends for Safety and Appreciation On Monday AM we thought blue chip drug and biotech stocks were poised to rally and we were rewarded. The S&P has come back to early August depressed levels but we have a double bottom in August. Healthcare overall was up 0.53% today...